VIEWRAY INC (VRAY) Stock Price, Quote, News and Overview
NASDAQ:VRAY - Nasdaq - US92672L1070 - Common Stock - Currency: USD
VRAY Quote, Performance and Key Statistics
0.025
-0.02 (-39.9%)
The current stock price of VRAY is 0.025 USD. In the past month the price decreased by -93.75%. In the past year, price decreased by -99.18%.
VRAY Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About VRAY
Company Profile
ViewRay, Inc. designs, manufactures, and markets the MRIdian MRI-guided Radiation Therapy System. The company is headquartered in Oakwood Village, Ohio and currently employs 295 full-time employees. The company went IPO on 2014-11-04. The MRIdian MR-Guided Radiation Therapy System integrates diagnostic MR imaging with radiation therapy delivery to enable on-table adaptive treatments with real-time tissue tracking and automatic beam gating. The MRIdian is comprised of three components, namely magnetic resonance imaging (MRI) system, radiation delivery system, and integrated treatment planning and delivery software. MRIdian employs MRI-based technology to provide real-time imaging that targets tumors from the surrounding soft tissue and other critical organs, both before and during radiation treatment delivery. MRIdian offers MR-guided imaging that provides tissue visualization compared to cone-beam computed tomography (CBCT), to enable contouring and reduced margins. The firm has installed approximately 56 MRIdian systems at hospitals, which are used to treat a variety of solid tumors.
Company Info
VIEWRAY INC
2 Thermo Fisher Way
Oakwood Village OHIO 44146 US
CEO: Scott Drake
Employees: 295
Company Website: https://viewray.com/
Phone: 14407033210.0
VIEWRAY INC / VRAY FAQ
What is the stock price of VIEWRAY INC today?
The current stock price of VRAY is 0.025 USD. The price decreased by -39.9% in the last trading session.
What is the ticker symbol for VIEWRAY INC stock?
The exchange symbol of VIEWRAY INC is VRAY and it is listed on the Nasdaq exchange.
On which exchange is VRAY stock listed?
VRAY stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VIEWRAY INC stock?
12 analysts have analysed VRAY and the average price target is 1.22 USD. This implies a price increase of 4796% is expected in the next year compared to the current price of 0.025. Check the VIEWRAY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VIEWRAY INC worth?
VIEWRAY INC (VRAY) has a market capitalization of 4.58M USD. This makes VRAY a Nano Cap stock.
How many employees does VIEWRAY INC have?
VIEWRAY INC (VRAY) currently has 295 employees.
Is VIEWRAY INC (VRAY) expected to grow?
The Revenue of VIEWRAY INC (VRAY) is expected to decline by -9.41% in the next year. Check the estimates tab for more information on the VRAY EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy VIEWRAY INC (VRAY) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VRAY, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VRAY, evaluating the profitability, health, valuation and growth aspects
- VIEWRAY INC (VRAY) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VIEWRAY INC (VRAY) Sales and EPS estimates to see what analysts future expectations are.
- VIEWRAY INC (VRAY) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VIEWRAY INC (VRAY) Insider and Institutional Ownership to learn about the owners and their transactions.
- VIEWRAY INC (VRAY) Stock Chart to make your own analysis
- VIEWRAY INC (VRAY) Latest news and press-releases to stay up to date.
Does VIEWRAY INC (VRAY) stock pay dividends?
VRAY does not pay a dividend.
When does VIEWRAY INC (VRAY) report earnings?
VIEWRAY INC (VRAY) will report earnings on 2023-10-30, after the market close.
What is the Price/Earnings (PE) ratio of VIEWRAY INC (VRAY)?
VIEWRAY INC (VRAY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.6).
VRAY Technical Analysis
VRAY Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VRAY. The financial health of VRAY is average, but there are quite some concerns on its profitability.
VRAY Financial Highlights
Over the last trailing twelve months VRAY reported a non-GAAP Earnings per Share(EPS) of -0.6. The EPS increased by 6.25% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
VRAY Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 73% to VRAY. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 12.95% and a revenue growth -9.41% for VRAY